Pericardial mesothelioma

Current treatment options in oncology

Volumn 1, Issue 4, 2000, Pages 299-302

  Vigneswaran, Wickii Thambiah ^a,b   Stefanacci, Paul Robert ^a,b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CLINICAL TRIAL; HEART TUMOR; HUMAN; MESOTHELIOMA; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PERICARDIUM; RADIOTHERAPY; REVIEW; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HEART NEOPLASMS; HUMANS; MESOTHELIOMA; PERICARDIUM; RADIOTHERAPY; SURVIVAL RATE;

EID: 0034308887     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-000-0045-6     Document Type: Review

References (21)

1. 1. JL Cohen 1976 Neoplastic pericarditis Cardiaovasc Clin 7 257 268 1:STN:280:DyaE2s%2Fms12iuw%3D%3D Cohen JL: Neoplastic pericarditis. Cardiaovasc Clin 1976, 7:257–268.
2. 2. AD McDonald A Harper Attar GA El JC McDonald 1970 Epidemiology of primary malignant mesothelial tumors in Canada Cancer 26 914 919 5506612 10.1002/1097-0142(197010)26:4<914::AID-CNCR2820260427>3.0.CO;2-H 1:STN:280:DyaE3M%2Fgt1ensQ%3D%3D McDonald AD, Harper A, El Attar GA, McDonald JC: Epidemiology of primary malignant mesothelial tumors in Canada. Cancer 1970, 26:914–919.
3. 3. EI Kahn 1980 Primary pericardial mesothelioma following exposure to asbestos Environ Res 23 270 281 7472312 10.1016/0013-9351(80)90061-4 1:STN:280:DyaL3M7jvVWmtA%3D%3D Kahn EI: Primary pericardial mesothelioma following exposure to asbestos. Environ Res 1980, 23:270–281.
4. 4. A Churg ML Warnock KG Bersch 1978 Malignant mesothelioma arising after direct application of asbestos and fibreglass to the pericardium Am Rev Respir Dis 118 419 424 697191 1:STN:280:DyaE1M%2FhvFGrtw%3D%3D Churg A, Warnock ML, Bersch KG: Malignant mesothelioma arising after direct application of asbestos and fibreglass to the pericardium. Am Rev Respir Dis 1978, 118:419–424.
5. 5. U Bohn JL Gonzalez LM Martin 1994 Meningeal and brain metastases in primary malignant pericardial mesothelioma Ann Oncol 5 660 661 7993848 1:STN:280:DyaK2M%2Fos1SisA%3D%3D Bohn U, Gonzalez JL, Martin LM, et al.: Meningeal and brain metastases in primary malignant pericardial mesothelioma Ann Oncol 1994, 5:660–661.
6. 6. O Lund OK Hansen S Ardest U Baandrup 1987 Primary malignant pericardial mesothelioma mimicking left atrial myxoma Scand J Thorac Cardiovasc Surg 21 273 275 3438724 1:STN:280:DyaL1c7ksFGkuw%3D%3D Lund O, Hansen OK, Ardest S, Baandrup U: Primary malignant pericardial mesothelioma mimicking left atrial myxoma. Scand J Thorac Cardiovasc Surg 1987, 21:273–275.
7. 7. DSC Rose WT Vigneswaran JF Bovill 1992 Primary pericardial mesothelioma presenting as tuberculous pericarditis Postgrad Med J 68 137 139 1570257 1:STN:280:DyaK383jslWqtw%3D%3D 10.1136/pgmj.68.796.137 Rose DSC, Vigneswaran WT, Bovill JF, et al.: Primary pericardial mesothelioma presenting as tuberculous pericarditis. Postgrad Med J 1992, 68:137–139.
8. 8. FP Yilling RC Schlant GL Hertzler R Krzyaniak 1982 Pericardial mesothelioma Chest 81 520 523 7067523 1:STN:280:DyaL387msVSlsw%3D%3D Yilling FP, Schlant RC, Hertzler GL, Krzyaniak R: Pericardial mesothelioma. Chest 1982, 81:520–523.
9. 9. R Thomason W Schlegel M Lucca 1994 Primary malignant mesothelioma of the pericardium Texas Heart Inst J 21 170 174 1:STN:280:DyaK2czjvFOnsQ%3D%3D Thomason R, Schlegel W, Lucca M, et al.: Primary malignant mesothelioma of the pericardium. Texas Heart Inst J 1994, 21:170–174.
10. 10. TK Kaul BL Fields DR Kahn 1994 Primary malignant pericardial mesothelioma: a case report and review J Cardiovasc Surg 35 261 267 1:STN:280:DyaK2czhsVOrsA%3D%3D Kaul TK, Fields BL, Kahn DR: Primary malignant pericardial mesothelioma: a case report and review. J Cardiovasc Surg 1994, 35:261–267.
11. 11. AS Agatston MJ Robinson L Trigo 1986 Echocardiographic findings in primary pericardial mesothelioma Am Heart J 111 986 988 3706117 10.1016/0002-8703(86)90651-4 1:STN:280:DyaL283htFyntQ%3D%3D Agatston AS, Robinson MJ, Trigo L, et al.: Echocardiographic findings in primary pericardial mesothelioma. Am Heart J 1986, 111:986–988.
12. 12. HD Gossinger P Siostrzonek M Zangeneh 1988 Magnetic resonance imaging findings in a patient with pericardial mesothelioma Am Heart J 115 1321 1322 3376853 10.1016/0002-8703(88)90033-6 1:STN:280:DyaL1c3jvVeksA%3D%3D Gossinger HD, Siostrzonek P, Zangeneh M, et al.: Magnetic resonance imaging findings in a patient with pericardial mesothelioma. Am Heart J 1988, 115:1321–1322.
13. 13. T Nishikimi H Ochi K Hirota 1987 Primary pericardial mesothelioma detected by gallium-67 scintigraphy J Nucl Med 28 1210 1212 3474368 1:STN:280:DyaL2s3ltlCitw%3D%3D Nishikimi T, Ochi H, Hirota K, et al.: Primary pericardial mesothelioma detected by gallium-67 scintigraphy. J Nucl Med 1987, 28:1210–1212.
14. 14. AP Chahinian K Antman J Aisner 1993 A randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma J Clin Oncol 11 1559 1565 8336195 1:STN:280:DyaK3szivFGjsw%3D%3D Chahinian AP, Antman K, Aisner J, et al.: A randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma. J Clin Oncol 1993, 11:1559–1565.
15. 15. Breau JL, Boaziz C, Morere JJF, et al.: Combination chemotherapy with cisplatinum, adriamycin, bleomycin, and mitomycin C, plus systemic and intrapleural hyaluronidase in 25 consecutive cases of stage II, III pleural mesothelioma. Paper presented at: First International Mesothelioma Conference; 1991; Paris, France.
16. 16. JP Meerback Van P Bass C Debruyne 1999 A phase II study of Gemcitabine in patient with malignant pleural mesothelioma Cancer 85 2577 2582 10.1002/(SICI)1097-0142(19990615)85:12<2577::AID-CNCR13>3.0.CO;2-S This is a phase II European study using single-agent gemcitabine with promising results in patients with pleural mesothelioma. This would be a reasonable approach for patients diagnosed with primary pericardial mesothelioma. Van Meerback JP, Bass P, Debruyne C, et al.: A phase II study of Gemcitabine in patient with malignant pleural mesothelioma. Cancer 1999, 85:2577–2582. This is a phase II European study using single-agent gemcitabine with promising results in patients with pleural mesothelioma. This would be a reasonable approach for patients diagnosed with primary pericardial mesothelioma.
17. 17. DJ Sugarbaker RM Flores MT Jaklitsch 1999 Resection margin, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients J Thorac Cardiovasc Surg 117 54 65 9869758 10.1016/S0022-5223(99)70469-1 1:STN:280:DyaK1M7gt1Ghug%3D%3D The current and aggressive approach for selected patients with pleural mesothelioma. This is a large study; the authors discuss the evolution of pharmacologic therapy during the last decade in this setting. This would be an aggressive approach for primary pericardial mesothelioma using current technology and drugs. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al.: Resection margin, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999, 117:54–65. The current and aggressive approach for selected patients with pleural mesothelioma. This is a large study; the authors discuss the evolution of pharmacologic therapy during the last decade in this setting. This would be an aggressive approach for primary pericardial mesothelioma using current technology and drugs.
18. 18. CA Nambiar HE Tareif KU Kishore 1992 Primary pericardial mesothelioma: one-year event free survival Am Heart J 124 802 803 1514518 10.1016/0002-8703(92)90301-B 1:STN:280:DyaK38zosVajsA%3D%3D Nambiar CA, Tareif HE, Kishore KU, et al.: Primary pericardial mesothelioma: one-year event free survival. Am Heart J 1992, 124:802–803.
19. 19. RV Bowman LS Manning MR Davis BWS Robinson 1991 Chemosensitivity and cytokine sensitivity of malignant mesotheliomas Cancer Chemother Pharmacol 28 420 426 1934246 10.1007/BF00685817 1:CAS:528:DyaK38XpvV2lsQ%3D%3D Bowman RV, Manning LS, Davis MR, Robinson BWS: Chemosensitivity and cytokine sensitivity of malignant mesotheliomas. Cancer Chemother Pharmacol 1991, 28:420–426.
20. 20. HW Pass BK Temeck K Kranda 1995 A phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and feasibility of adjuvant immunochemotherapy after maximal cytoreduction Ann Surg Oncol 2 214 220 7641017 10.1007/BF02307026 1:STN:280:DyaK2MzmvVCgug%3D%3D Pass HW, Temeck BK, Kranda K, et al.: A phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and feasibility of adjuvant immunochemotherapy after maximal cytoreduction. Ann Surg Oncol 1995, 2:214–220.
21. 21. WR Smythe HG Hwang AA Elshami 1995 Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene Ann Surg 222 78 86 7618973 10.1097/00000658-199507000-00013 1:STN:280:DyaK2MzksVarsA%3D%3D Smythe WR, Hwang HG, Elshami AA, et al.: Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene. Ann Surg 1995, 222:78–86.